MyShare
Key factors
| sym | NMRD |
| exch | US |
| MCap | 2066.31K |
| Beta | -0.09 |
| EPS | -0.39 |
| Div date | 0000-00-00 |
Yesterday
| sym | NMRD |
| exch | US |
| close | 0.079 |
| 50 Day MA | 0.082 |
| 200 Day MA | 0.355 |
| 52 Week High | 1.25 |
| 52 Week Low | 0.068 |
| Target Price | 1.5 |
| Market Cap Mln | 2.066 |
Share statistics
| Shares Outstanding | 28.89M |
| Shares Float | 14.83M |
| Percent Institutions | 4.422 |
| PercentInsiders | 48.62 |
| SharesShort | 52568 |
| Short Ratio | 0.3 |
| Shares Short Prior Month | 212.67K |
| Short Percent | 0.310 |
Income
| Quarterly Revenue Growth YOY | -100.0 |
| Gross Profit TTM | -1476.3K |
| EBITDA | -11.2M |
| Diluted Eps TTM | -0.39 |
earning
| EPS Estimate Current Quarter | -0.12 |
| EPS Estimate Current Year | -0.32 |
| EPS Estimate Next Quarter | -0.11 |
| EPS Estimate Next Year | -0.44 |
| Earnings Share | -0.39 |
Dividend
| Dividend Date | 2019-12-05 |
| Last Split Date | 2019-12-05 |
| Last Split Factor | 1:10 |
business
| Enterprise Value Ebitda | -4.90 |
| Enterprise Value Revenue | 7183.65 |
| Book Value /share | -0.61 |
| Price Book MRQ | 122.56 |
| Price Sales TTM | 766.30 |
| ReturnOnAssetsTTM | -0.81 |
| ReturnOnEquityTTM | -7.24 |
Sector
| Gic Group | Health Care Equipment & Services |
| Gic Industry | Health Care Equipment & Supplies |
| Gic Sector | Health Care |
| Gic Sub Industry | Health Care Equipment |
| Industry | Medical Devices |
| Sector | Healthcare |
Codes
| ISIN | US6404422080 |
| CIK | 1602078 |
| Code | NMRD |
| CUSIP | 640442208 |
| Employer Id Number | 46-5027260 |
| CountryISO | US |
| Currency Code | USD |
| Currency Name | US Dollar |
| Exchange | NASDAQ |
| Currency Symbol | $ |
fund
| Type | Common Stock |
| UpdatedAt | 2024-04-05 |
| Home Category | Domestic |
info
| Fiscal Year End | March |
| Full Time Employees | 36.0 |
| IPODate | 2016-03-04 |
| International Domestic | Domestic |
| MostRecent Quarter | 2023-12-31 |
Contact
| Name | Nemaura Medical Inc |
| Address | 57 West 57th Street, New York, NY, United States, 10019 |
| Country Name | USA |
| Phone | 646 416 8000 |
| Web URL | https://nemauramedical.com |
| Logo URL | /img/logos/US/NMRD.png |
Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.